Literature DB >> 30431549

Lung cancer screening: Practice guidelines and insurance coverage are not enough.

Karen Kane McDonnell1, Robin Dawson Estrada1, Amy Clark Dievendorf1, Lauren Blew1, Erica Sercy2, Samira Khan2, James W Hardin3, Deborah Warden1, Jan M Eberth3.   

Abstract

BACKGROUND AND
PURPOSE: Low-dose computed tomography (LDCT) is expected to increase early detection of lung cancer and improve survival. The growth in the number of advanced nurse practitioners (NPs) in primary care settings increases the likelihood that an NP will serve as a patient's provider. This study's purpose was to examine knowledge, attitudes, and practices regarding LDCT among NPs who work in primary care settings.
METHODS: An explanatory, sequential, mixed-method design used a 32-item questionnaire, followed by a semi-structured telephone interview. The development of the survey and interview questions were guided by a conceptual framework representing a temporal sequence for behavior change and potential barriers to guideline adherence.
CONCLUSIONS: Nurse practitioners believe that shared decision making with their high-risk patients about LDCT is within their scope of their practice. Working in time-constrained primary care settings, NPs have limited abilities to improve the uptake of LDCT. Substantial patient barriers exist that deter follow through on providers' recommendation. Disseminating guidelines and authorizing health insurance reimbursement is insufficient. IMPLICATIONS FOR PRACTICE: Research is needed that investigates the screening process so that barriers can be closely studied. Culture change is needed where early detection has greater value for insurers, providers, and patients.

Entities:  

Mesh:

Year:  2019        PMID: 30431549      PMCID: PMC6487865          DOI: 10.1097/JXX.0000000000000096

Source DB:  PubMed          Journal:  J Am Assoc Nurse Pract        ISSN: 2327-6886            Impact factor:   1.165


  1 in total

1.  Outcomes of Shared Decision-Making for Low-Dose Screening for Lung Cancer in an Academic Medical Center.

Authors:  Jan M Eberth; Anja Zgodic; Scott C Pelland; Stephanie Y Wang; David P Miller
Journal:  J Cancer Educ       Date:  2022-04-30       Impact factor: 2.037

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.